New Treatment for Opioid-Induced Constipation

Author/Creator ORCID

Date

2015-01

Department

Sandra R. Berman School of Nursing and Health Professions

Program

Nursing

Citation of Original Publication

Aschenbrenner, D. S. (2015). New treatment for opioid-induced constipation. AJN American Journal of Nursing, 115(1), 23. doi:10.1097/01.NAJ.0000459622.00045.fd

Rights

Subjects

Abstract

The opioid antagonist naloxegol (Movantik) is now approved to treat opioid-induced constipation in adults with chronic noncancer pain. The most common adverse effects are abdominal pain, diarrhea, nausea, flatulence, vomiting, and headache.